The Myasthenia Alliance Australia is partnering withOPTIMAL NHMRC Centre for Research Excellence in improving immunoglobulin use.

There is just 1 week to go until our informative webinar on Myasthenia Gravis!

Date: Monday 24th November 2025

Times:

• Eastern daylight-saving states (NSW, VIC, TAS, ACT): 3:00 – 4:30 PM
• Queensland: 2:00 – 3:30 PM
• South Australia: 2:30 – 4:00 PM
• Northern Territory: 1:30 – 3:00 PM
• Western Australia: 12:00 – 1:30 PM 

Why attend?

As a patient, you can learn more about current research and how it has an impact on our healthcare and the therapies we can access. 

The program covers the current understanding of Myasthenia Gravis, insights from national research on immunoglobulin therapy in Myasthenia Gravis, and how patient preferences can help shape future care. The MAA will also present on the lived experience of MG patients.

Presentations will be followed by a Q&A with all speakers so don’t miss this opportunity to learn and ask your questions to clinicians and researchers!

For more information and to register, scan the QR code on the flyer or click here.

View the program here.

Please feel free to share this invitation with your networks or anyone who may be interested – all are welcome to attend.

We look forward to you joining us.